Aquestive Therapeutics (AQST) Stock Highlights

4.95 | +3.34%

2024-09-19 04:31:18

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Statistics

Range Today

4.76 5.11

Volume Today 1.13M

Range 1 Year

1.25 6.23

Volume 1 Year 350.85M

Range 3 Year

0.62 6.4

Volume 3 Year 619.53M

Range 10 Year

0.62 20.696

Volume 10 Year 1.06B

Highlights

Market Capitalization 440.73M (small)

Floating Shares 79.98M

Current Price 4.95

Price To Earnings -12.78

Price To Revenue 6.62

Earnings Per Share -0.36

Payout Ratio 0%

Performance

Latest +3.34%

1 Month +15.65%

3 Months +79.35%

6 Months -20.55%

1 Year +205.56%

3 Years +21.62%

5 Years +37.5%

10 Years -67.22%

Benchmarks

Market Capitalization

220 / 368

Gross Profits

74 / 278

Total Revenue

126 / 300

Total Rank

135 / 368

Free Cashflow

116 / 352

Performance 5 years

101 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.